Kolesystokiiniini
Kolesystokiiniini is a synthetic peptide that has gained attention for its potential therapeutic applications, particularly in the field of neurodegenerative diseases. It is a truncated form of the human kininogen-1 protein, which is involved in the regulation of the inflammatory response. Kolesystokiiniini is known for its ability to cross the blood-brain barrier, making it a promising candidate for the treatment of conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
The peptide is composed of 14 amino acids and has been shown to have neuroprotective properties. It
Clinical studies have explored the potential of kolesystokiiniini in the treatment of Alzheimer's disease, with some